Table: OncoTherapy Science - 6-MTH group results
Nov 2 (Reuters)-
OncoTherapy Science Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2017 Sep 30, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 201 mln 34 mln
(+485.7 pct) (-83.5 pct)
Operating loss 1.43 loss 1.52
Recurring loss 1.42 loss 1.50
Net loss 1.37 loss 1.50
EPS loss 9.30 yen loss 10.18 yen
Ann Div NIL NIL
-Q2 div
-Q4 div NIL NIL
NOTE - OncoTherapy Science Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T
((Tokyo Headline News Desk +813 6441 1812))